MedTrace Logo

Prospective Evaluation for Hybrid Cardiac Procedures

NCT05143671 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2025-08-14

No results posted yet for this study

Summary

Multidisciplinary team-approach in order to offer personalized treatments represents the emerging mainstream in cardiovascular medicine. "Hybrid operative rooms" allow to offer selected heart-disease patients truly "tailored" operations.

This study wants to evaluate the effectiveness and safety of Hybrid Procedures in cardiac patients in three subgroups of patients:

* Hybrid coronary revascularization strategy (coronary by-pass + PCI);
* Hybrid valve and coronary disease correction (combination of surgical valve replacement and PCI);
* Hybrid coronary and carotid artery disease treatment (combination of coronary by-pass and carotid stenting).

The investigators hypothesize that morbidity might be reduced by 50% in hybrid procedures group as compared with predicted Society of Thoracic Surgery (STS) score.

Conditions

  • Left Main Coronary Artery Disease
  • Left Anterior Descending Coronary Artery Stenosis
  • Valve Disease, Heart
  • Carotid Stenosis
  • Coronary Artery Disease
  • Heart Diseases
  • Heart Valve Diseases
  • Carotid Occlusion

Interventions

PROCEDURE

Coronary artery bypass grafting

Coronary artery bypass grafting in coronary revascularization.

PROCEDURE

Percutaneous coronary intervention

Percutaneous coronary intervention in coronary revascularization.

PROCEDURE

Surgical valve replacement

Surgical mitral and / or aortic valve replacement.

PROCEDURE

Carotid artery stenting

Carotid artery stenting.

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Piergiorgio Bruno, MD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-13
Primary Completion
2025-07-30
Completion
2025-07-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05143671 on ClinicalTrials.gov